Engineering Improved Stem Cell-Derived Islet Cells for Replacement Therapies
Department of Health and Human Services ▸ National Institutes of Health
Description
The National Institute of Diabetes and Digestive and Kidney Diseases will soon announce a funding opportunity for research on enhancing the characteristics of stem cell-derived islet cell products to improve cell replacement therapy. This research will focus on the engineering of these cell products to make them more resilient and functional, compared to those derived from human cadavers. The funding aims to support studies that explore engineering targets and pathways, as well as preclinica…
The National Institute of Diabetes and Digestive and Kidney Diseases intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for research on understanding how to engineer inherent characteristics of stem cell-derived islet cell products that can result in improved…
Source
Grant ID
NOT-DK-26-306
Funding Source
Department of Health and Human Services ▸ National Institutes of Health
Eligibility
The following categories of applicants are invited to apply:
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- Public housing authorities/Indian housing authorities
- Small businesses
- Public and State controlled institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- County governments
- Independent school districts
- For profit organizations other than small businesses
- State governments
- Native American tribal governments (Federally recognized)
- City or township governments
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Awards & Funding
Total Funding
$3M
Funding Amount
Discretionary
Links
Similar opportunities
- Notice of Intent to Publish a Funding Opportunity Announcement for Single Source for Continuation of the Integrated Islet Distribution Program (UC4)
- Notice of Funding Opportunity for Studies on Type 1 Diabetes Etiology and Pathogenesis
- Accelerating Product Excellence in Innovation and for Clinical Adoption (APEx) (U24 Clinical Trial Not Allowed)
- Notice of Special Interest (NOSI): Somatic Cell Gene Editing Therapies to Improve Transplantation Outcomes
- Limited Competition: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Studies (U01 Clinical Trial Not Allowed)